Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Banca Mediolanum S.p.A (BMED.MI)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-03-307.919.00Buy
2022-04-296.988.80Buy
2022-06-087.128.60Buy
2022-07-226.248.30Buy
2022-08-266.288.50Buy
2022-10-277.518.70Buy
2022-12-017.889.30Buy
2023-02-038.9310.00Buy
2023-02-219.0010.40Buy
2023-07-048.159.70Buy
2023-10-247.679.20Buy
2024-01-319.4910.90Buy
2024-02-129.9011.80Buy
2024-04-3010.1811.90Buy
2024-05-1510.8412.30Buy
2024-08-089.9012.50Buy
2025-02-0413.0514.00Buy
2025-04-3013.1214.50Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.